Professional
Added to YB: 2024-04-18
Pitch date: 2024-04-14
LFCR [bullish]
Lifecore Biomedical, Inc.
+17.65%
current return
Author Info
White Falcon Capital is a value-investing fund that aspires to buy and hold a collection of wonderful publicly listed businesses run by aligned and like-minded managers and owners. Follow on Twitter/X.
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.
Market Cap
$268.3M
Pitch Price
$6.12
Price Target
N/A
Dividend
N/A
EV/EBITDA
-119.93
P/E
-5.62
EV/Sales
3.39
Sector
Life Sciences Tools and Services
Category
growth
MWhite Falcon Capital Management Portfolio Holding: Lifecore Biomedical, Inc.
LFCR: CDMO specializing in complex injectables. Stock down to $4.5 after strategic process ended without deal, avg cost now $5.3. Expertise & compliance are key in this space. Expanding capacity from 22M to 70M units over 4yrs, enabling 2-3x rev growth & ~3x earnings growth. Most capex already done, huge FCF potential ahead.
Read full article (2 min)